Ga. Nuttall et al., Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass, ANESTHESIOL, 94(5), 2001, pp. 773-781
Citations number
33
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Background: Abnormal bleeding after cardiopulmonary bypass (CPB) is a commo
n complication of cardiac surgery, with important health and economic conse
quences. Coagulation test-based algorithms may reduce transfusion of non-er
ythrocyte allogeneic blood in patients with abnormal bleeding.
Methods: The authors performed a randomized prospective trial comparing all
ogeneic transfusion practices in 92 adult patients with abnormal bleeding a
fter CPB. Patients with abnormal bleeding were randomized to one of two gro
ups: a control group following individual anesthesiologist's transfusion pr
actices and a protocol group using a transfusion algorithm guided by coagul
ation tests.
Results: Among 836 eligible patients having all types of elective cardiac s
urgery requiring CPB, 92 patients developed abnormal bleeding after CPB (in
cidence, 11%). The transfusion algorithm group received less allogeneic fre
sh frozen plasma in the operating room after CPB (median, 0 units; range, 0
-7 units) than the control group (median, 3 units; range, 0-10 units) (P =
0.0002). The median number of platelet units transfused in the operating ro
om after CPB was 4 (range, 0-12) in the algorithm group compared with 4 (ra
nge, 0-18) in the control group (P = 0.0001). Intensive care unit (ICU) med
iastinal blood loss was significantly less in the algorithm group. Multivar
iate analysis demonstrated that transfusion algorithm use resulted in reduc
ed ICU blood loss. The control group also had a significantly greater incid
ence of surgical reoperation of the mediastinum for bleeding (11.8% vs. 0%;
P = 0.032).
Conclusions: Use of a coagulation test-based transfusion algorithm in cardi
ac surgery patients with abnormal bleeding after CPB reduced non-erythrocyt
e allogeneic transfusions in the operating room and ICU blood loss.